Agios Pharmaceuticals Inc

AGIONASDAQ · USD
32.90USD-1.29 (-3.78%)
235

Agios Pharmaceuticals Inc (AGIO) Option Chain

As of September 23, 2026, Agios Pharmaceuticals Inc is trading at $32.90, a -3.78% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 67.9%. IV Rank is 59%.

Read more

Tracking the AGIO option chain helps you see every strike and expiry on Agios Pharmaceuticals Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Agios Pharmaceuticals Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of AGIO options activity at a glance. Use our scanner to monitor the AGIO option chain in real time and filter for the AGIO options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For AGIO stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the AGIO option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where AGIO stock options are being actively traded and where they are not.

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Agios Pharmaceuticals Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen AGIO options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of AGIO stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile80.56% Elevated
  • Market cap (M$)2,041
  • 52 weeks high-25.67%
  • 52 weeks low53.73%
  • Analyst recommendationBuy
    1.60
  • Target price$46.25
    39.06% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-29
  • P/E—
  • Future P/E—
  • EPS (ttm)-7.01
  • EPS growth next 5 years37.77%

As of September 23, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.54001.8010.4010.1014.3022.50-35.66—1.800.001.800499.46
2.71002.307.908.0012.4025.00-28.51—4.800.004.8004397.29
19.99102.352.903.507.0030.00-14.210.204.700.002.45028480.01
52.95415262.380.002.102.6535.00+0.091.852.502.100.0797147.05
80.719410.800.000.650.9540.00+14.384.708.007.10-0.750019.29

As of September 23, 2026

Scan the full option chain in one place

Browse the full AGIO option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial